GeneDx Holdings
WGS
45.46
-3.78
-7.68%
GeneDx Holdings
US · WGS
#2702 by market cap
Listed 1970
45.46
-3.78
-7.68%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About GeneDx Holdings
GeneDx Holdings Corp. is a rare disease diagnosis company, with a mission to empower everyone to live their healthiest life through genomics. The firm combines clinical expertise, advanced technology, and the power of GeneDx Infinity. This foundation powers GeneDx's ExomeDx and GenomeDx tests, enabling clinicians to deliver precise, fast, and actionable diagnoses. The Infinity also fuels discovery for biopharma with AI-driven genomic intelligence. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
- Founded
- 2020
- CEO
- Ms. Katherine A. Stueland
- Employees
- 1,300
- Headquarters
- Stamford, Connecticut, United States of America
- Fiscal year end
- 12-31
- Website
- genedx.com
Company profile
- Exchange
- US
- Symbol
- WGS
- Market-cap rank
- #2702
- Listing date
- 1970-01-01
- Market cap
- 1.36B
- Float cap
- 854.34M
- Shares out
- 29.97M
- Float shares
- 18.79M
Sectors & themes
Diagnostics & Research
Fractional Shares JP
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
GeneDx Holdings discussion 0 comments